Enhanced quadrivalent vaccine against seasonal influenza for the 2022/2023 flu season

Folkehelseinstituttet

The Norwegian Institute of Public Health (NIPH) would like to procure a enhanced 4-valent vaccine against seasonal influenza for vaccinating nursing home residents aged 65 or older. An enchanced 4-valent influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups in the national vaccination programme.
The procurement will follow the rules for an open tender contest in accordance with the Public Procurements Act and regulations (FOA) parts 1 and 3, and will be made electronically in the contracting authority's electronic contest management tool, CTM (EU-Supply).
The aim is to enter into a contract for the delivery of 40,000 doses of enhanced 4-valent influenza vaccines. The tender documentation specifies the minimum requirements for the vaccine.
A contract will be signed with one tenderer.

Frist

Fristen for mottak av tilbud var 2022-01-31. Anskaffelsen ble publisert 2021-12-21.

Leverandører

Følgende leverandører er nevnt i tildelingsbeslutninger eller andre anskaffelsesdokumenter:

Hvem? Hva? Hvor?
Anskaffelseshistorikk
Dato Dokument
2021-12-21 Kunngjøring av konkurranse
2022-04-25 Kunngjøring om tildeling av kontrakt
Kunngjøring av konkurranse (2021-12-21)
Gjenstand
Anskaffelsens omfang
Tittel: Influenza vaccines
Referansenummer: 21/17157
Kort beskrivelse:
The Norwegian Institute of Public Health (NIPH) would like to procure a enhanced 4-valent vaccine against seasonal influenza for vaccinating nursing home residents aged 65 or older. An enchanced 4-valent influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups in the national vaccination programme. The procurement will follow the rules for an open tender contest in accordance with the Public Procurements Act and regulations (FOA) parts 1 and 3, and will be made electronically in the contracting authority's electronic contest management tool, CTM (EU-Supply). The aim is to enter into a contract for the delivery of 40,000 doses of enhanced 4-valent influenza vaccines. The tender documentation specifies the minimum requirements for the vaccine. A contract will be signed with one tenderer.
Vis mer
Metadata for kunngjøring
Originalspråk: engelsk 🗣️
Dokumenttype: Kunngjøring av konkurranse
Kontraktens art: Varer
Forskrift: Det europeiske økonomiske samarbeidsområdet (EØS), med deltakelse av GPA-land
Felles innkjøpsordliste (CPV)
Kode: Influensavaksine 📦
Tilleggs-CPV: Vaksiner 📦
Utførelsessted
NUTS-region: Norge 🏙️

Prosedyre
Prosedyretype: Åpen anbudskonkurranse
Tilbudstype: Innlevering for alle delkontrakter
Tildelingskriterier
Laveste pris

Oppdragsgiver
Identitet
Land: Norge 🇳🇴
Type tildelende myndighet: Departement eller annen nasjonal eller føderal myndighet
Navn på tildelende myndighet: Folkehelseinstituttet
Postadresse: Lovisenberggata 8
Postnummer: 0456
Poststed: Oslo
Kontakt
Internettadresse: http://www.fhi.no 🌏
E-post: ole.andreas.fuglesang@fhi.no 📧
Telefon: +47 21076629 📞
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=319795&B=DFO 🌏
URL for deltakelse: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=319795&B=DFO 🌏

Referanse
Datoer
Sendt dato: 2021-12-21 📅
Innleveringsfrist: 2022-01-31 📅
Publiseringsdato: 2021-12-24 📅
Identifikatorer
Kunngjøringsnummer: 2021/S 250-665336
OJ-S-utgave: 250
Tilleggsinformasjon
Clarification regarding the duration of the agreement stated in section II.2.7 of the tender notice: The actual duration of the contract is stated in the Supply Agreement's chapter 17 "Duration and Termination". In the event of any conflict between the tender notice's section II.2.7 and the Supply Agreement, the Supply Agreement ranks highest.
Vis mer

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian Institute of Public Health (NIPH) would like to procure a enhanced 4-valent vaccine against seasonal influenza for vaccinating nursing home residents aged 65 or older. An enchanced 4-valent influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups in the national vaccination programme.
Vis mer
The procurement will follow the rules for an open tender contest in accordance with the Public Procurements Act and regulations (FOA) parts 1 and 3, and will be made electronically in the contracting authority's electronic contest management tool, CTM (EU-Supply).
Vis mer
The aim is to enter into a contract for the delivery of 40,000 doses of enhanced 4-valent influenza vaccines. The tender documentation specifies the minimum requirements for the vaccine.
A contract will be signed with one tenderer.
Estimert totalverdi: 13 000 000 NOK 💰
Estimert verdi eksklusive mva: 13 000 000 NOK 💰
Varighet: 10 måneder
Tilleggsinformasjon:
Clarification regarding the duration of the agreement stated in section II.2.7 of the tender notice:
The actual duration of the contract is stated in the Supply Agreement's chapter 17 "Duration and Termination". In the event of any conflict between the tender notice's section II.2.7 and the Supply Agreement, the Supply Agreement ranks highest.
Utførelsessted
Hovedsted eller utførelsessted: Oslo

Juridisk, økonomisk, finansiell og teknisk informasjon
Vilkår for deltakelse
Egnethet til å utøve yrkesvirksomheten:
Tenderers must be registered in a company register, professional register or a trade register in the country where the tenderer is established.
Documentation requirement:
Norwegian companies: Company registration certificate
Foreign tenderers: Verification showing that the tenderer is registered in a company register, professional register or a commerce register in the country where the tenderer is established.
Teknisk og faglig kapasitet:
The tenderer must have the requisite permissions to be able to fulfil the contract.
Documentation requirement:
If the tenderer is the manufacturer of the vaccine, permission must be presented from relevant authorities to manufacture pharmaceuticals.
If the tenderer is not the manufacturer of the vaccine, the requisite permissions from relevant authorities to trade in pharmaceuticals must be presented.
If the tenderer imports the vaccine, the import license that includes the offered vaccine must be presented.
Kontraktutførelse
Vilkår for kontraktoppfyllelse:
The Norwegian Institute of Public Health have requirements for ethically and socially responsible production (the Supply Agreement section 12.1-12.4)
Delivery: Full delivery by the end of week 43, 2022 (the Supply Agreement section 4.2)

Prosedyre
Rettslig grunnlag: 32014L0024
Tidspunkt for mottak av tilbud: 13:00
Språk som tilbud eller forespørsler om deltakelse kan sendes inn på: engelsk 🗣️
norsk 🗣️
Tilbudets gyldighetsperiode: 2022-03-31 📅
Dato for åpning av tilbud: 2022-01-31 📅
Tidspunkt for åpning av tilbud: 13:00
Sted: The tenders will be opened electronically in the Norwegian Institute of Public Health's tender management system (Norwegian: KGV).
Tilleggsinformasjon:
Two representatives from the Norwegian Institute of Public Health must log on and implement a separate opening each after the deadline has expired.

Oppdragsgiver
Identitet
Nasjonalt registreringsnummer: 983 744 516
Kontakt
Kontaktpunkt: Ole Andreas Fuglesang
Adresse til kjøperprofilen: https://eu.eu-supply.com/ctm/Company/CompanyInformation/Index/346372 🌏
URL for dokumenter: http://eu.eu-supply.com/app/rfq/rwlentrance_s.asp?PID=319795&B=DFO 🌏

Utfyllende informasjon
Klageinstans
Navn: Oslo tingrett
Postadresse: Postboks 2106 Vika
Poststed: Oslo
Postnummer: 0125
Land: Norge 🇳🇴
Telefon: +47 22035200 📞
E-post: oslo.tingrett@domstol.no 📧
Internettadresse: https://www.domstol.no/en/Enkelt-domstol/Oslo-District-Court/ 🌏
Kilde: OJS 2021/S 250-665336 (2021-12-21)
Kunngjøring om tildeling av kontrakt (2022-04-25)
Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian Institute of Public Health (NIPH) has procured a enhanced 4-valent vaccine against seasonal influenza for vaccinating nursing home residents aged 65 or older. An enhanced 4-valent influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups in the national vaccination programme. The procurement will follow the rules for an open tender contest in accordance with the Public Procurements Act and regulations (FOA) parts 1 and 3, and will be made electronically in the contracting authority's electronic contest management tool, CTM (EU-Supply). The aim was to enter into a contract for the delivery of 40,000 doses of enhanced 4-valent influenza vaccines. The tender documentation specified the minimum requirements for the vaccine. The only award criterium in the tender contest was the lowest price. A contract was signed with one tenderer.
Vis mer
Totalverdi for anskaffelsen: 13 000 000 NOK 💰
Metadata for kunngjøring
Dokumenttype: Kunngjøring om tildeling av kontrakt

Prosedyre
Tilbudstype: Ikke aktuelt

Referanse
Datoer
Sendt dato: 2022-04-25 📅
Publiseringsdato: 2022-04-29 📅
Identifikatorer
Kunngjøringsnummer: 2022/S 084-228483
Refererer til kunngjøring: 2021/S 250-665336
OJ-S-utgave: 84
Tilleggsinformasjon
The contract value stated in section II.1.7) of the tender notice represents the contracting authority's estimated value of the contract at the time of the publication of the contest. Pursuant to section §13 of the Freedom of Information Act and § 13, first paragraph, point 2) of the Public Administration Act, the real contract value is not published (ref. Section V.2.4 of the tender notice). Unit price (Price per dose) is the only price element in the contest. The contracting authority considers unit prices to be information of competitive importance to keep secret from the person to whom the information relates, who in this case is the winner of the contest. If the real contract value had been published in the tender notice, it would have been possible to calculate the unit price based on the contract value and publicly known information about the number of doses in the contract. The contracting authority informs that the contract value is above the Public Procurement Regulations' upper threshold value and lower than the estimated procurement value, cf. Section II.1.7)
Vis mer

Gjenstand
Anskaffelsens omfang
Kort beskrivelse:
The Norwegian Institute of Public Health (NIPH) has procured a enhanced 4-valent vaccine against seasonal influenza for vaccinating nursing home residents aged 65 or older. An enhanced 4-valent influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups in the national vaccination programme.
Vis mer
The aim was to enter into a contract for the delivery of 40,000 doses of enhanced 4-valent influenza vaccines. The tender documentation specified the minimum requirements for the vaccine.
The only award criterium in the tender contest was the lowest price. A contract was signed with one tenderer.
The Norwegian Institute of Public Health (NIPH) has procured an enhanced 4-valent vaccine against seasonal influenza for vaccinating nursing home residents aged 65 or older. An enchanced 4-valent influenza vaccine is a vaccine that is more effective than the ordinary influenza vaccine that is offered to other target groups in the national vaccination programme.
Vis mer

Tildeling av kontrakt
Dato for kontraktinngåelse: 2022-03-17 📅
Navn: Seqirus
Nasjonalt registreringsnummer: N/a
Postadresse: 29 Market St
Poststed: Maidenhead
Postnummer: SL6 8AA
Land: Storbritannia 🇬🇧
Telefon: +441 628641500 📞
E-post: ramon.guitart@seqirus.com 📧
Totalverdi for anskaffelsen: 1 NOK 💰
Informasjon om tilbud
Antall mottatte tilbud: 2

Referanse
Tilleggsinformasjon
The contract value stated in section II.1.7) of the tender notice represents the contracting authority's estimated value of the contract at the time of the publication of the contest.
Pursuant to section §13 of the Freedom of Information Act and § 13, first paragraph, point 2) of the Public Administration Act, the real contract value is not published (ref. Section V.2.4 of the tender notice).
Unit price (Price per dose) is the only price element in the contest. The contracting authority considers unit prices to be information of competitive importance to keep secret from the person to whom the information relates, who in this case is the winner of the contest. If the real contract value had been published in the tender notice, it would have been possible to calculate the unit price based on the contract value and publicly known information about the number of doses in the contract.
Vis mer
The contracting authority informs that the contract value is above the Public Procurement Regulations' upper threshold value and lower than the estimated procurement value, cf. Section II.1.7)
Kilde: OJS 2022/S 084-228483 (2022-04-25)
Nye anskaffelser i relaterte kategorier 🆕
Relaterte søk 🔍
Produkter/tjenester:
Medisinsk utstyr, legemidler og utstyr... Farmasøytiske produkter Antiinfektive midler for systemisk bruk,... Antiinfektive midler for systemisk bruk Vaksiner Influensavaksine